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esponsibility of InstAbstract This study aimed to investigate the ability of chelerythrine chloride (CHE), the main
active ingredient of Macleaya cordata, to induce apoptosis in human gastric cancer BGC-823 cells.
The results demonstrate that CHE inhibits cell proliferation in a time- and dose-dependent manner
with accompanying S phase arrest. It also induces apoptosis by a mechanism involving a reduction
in the mitochondrial membrane potential, the release of cytochrome c, activation of caspase 3 and
cleavage of poly-ADP-ribose polymerase. In addition, CHE-induced apoptosis is accompanied by
down-regulation of Bcl-xl and Bcl-2 proteins with no change in the levels of Bax proteins. Taken
together, the results support the development of CHE as a potentially useful anticancer drug for the
treatment of gastric cancer.
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Cancer is a universal public health problem because of its high
incidence and mortality rate. Currently, gastric carcinoma is
the second leading cause of cancer-related deaths in the
world1, accounting for about 23.2% of all cancer deaths2.
This is despite recent advances in the development of new
diagnostic and therapeutic tools. Consequently, it remains of
some urgency to identify new and better therapeutic agents
and regimes for gastric cancer.
Natural products, including plants, microorganisms and the
halobios provide a rich resource for the discovery of cytotoxic
agents3. Recently, much effort has been directed towards the
search for new plant sources of anticancer drugs. One plant
receiving attention is Macleaya cordata, a wild plant growing
in Shanxi, Guizhou and Yunnan provinces of China. It is
extensively used in traditional Chinese medicine for the
treatment of wounds, arthritis, rheumatic arthralgia and
trichomonas vaginalis4. Of particular relevance is that the
roots of Macleaya cordata have been applied in folk medicine
for the treatment of cancer5.
CHE (Fig. 1), a benzophenanthridine alkaloid, is the major
active ingredient of Macleaya cordata. It is reported to
mediate diverse biological and pharmacological effects
through its antimicrobial, antifungal, and anti-inﬂammatory
properties6,7. It also signiﬁcantly inhibits HaCaT keratinocytes
and exerts cytotoxic effects on various human normal and
cancer cell lines8–10. For instance CHE shows high cytotoxicity
against isolated rat hepatocytes and primary hepatocyte
cultures11. Induction of apoptosis has been mooted as a
possible mechanism of the anticancer activity of CHE12–15.
Recently, a differential induction of apoptosis was demon-
strated in cancer cells and normal cells in vitro, suggesting
CHE has potential as an effective anticancer drug10. To
conﬁrm the ability of CHE to induce apoptosis and to
investigate the exact mechanism of apoptosis induction, we
investigated the effect of CHE on gastric carcinoma BGC-823
cells in vitro.2. Materials and methods
2.1. Chemicals
CHE (purityZ99%) was provided by Yongfeng Boyuan
Industry Co. Ltd. (Jiangxi Province, China). RPMI-1640
medium were obtained from HyClone Laboratories Inc.
(Logan, UT, USA). A stock solution of CHE in DMSO was
diluted with RPMI-1640 medium to prepare standards with
concentrations of 1.25, 2.5, 5.0 and 10.0 mg/mL. The ﬁnalFigure 1 Structure of chelerythrine chloride.concentration of DMSO was less than 0.1%. DNase free
RNase A and propidium iodide (PI) were purchased from
Sigma (St. Louis, MO, USA). Cytochrome c antibody and
goat anti-rabbit-HRP were obtained from Santa Cruz Bio-
technology, Inc. (Santa Cruz, CA). Bid, Bax, Bcl-2, Bcl-xl,
caspase-3, b-actin and poly-ADP-ribose polymerase (PARP)
antibodies were purchased from Cell Signaling Technology
(Andover, MA, USA). All other chemicals were of the highest
grade available from commercial sources.2.2. Cell culture
The human gastric carcinoma cell line BGC-823 was pur-
chased from the Institute of Basic Medical Sciences, Chinese
Academy of Medical Sciences, and cultured in complete
RPMI-1640 medium supplemented with 10% v/v fetal bovine
serum (FBS), 100 units/mL penicillin and 100 mg/mL strepto-
mycin at 37 1C in a 5% CO2 incubator. Exponentially growing
cultures at 80% conﬂuence were used in all experiments.2.3. MTT assay
The cytotoxicity of CHE on BGC-823 cells was determined
using the [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium]
bromide (MTT) assay. The cells (2 105/mL) were seeded in a
96-well plate and, after 24 h, were treated with CHE solutions
and vehicle controls containing equivalent amounts of DMSO.
After incubation for 24, 36, and 48 h, 20 mL MTT solution
(5 mg/mL in PBS) was added to each well and incubated for an
additional 4 h. The plate was then centrifuged at 1000 rpm for
5 min, the supernatants were aspirated and the formazan
crystals in each well were dissolved in 100 mL aliquots of
DMSO. Finally, the plate was shaken and the optical density
was determined at 570 nm using a Model 680 Microplate
Reader (Bio-Rad, Bath, UK). Cell survival was expressed as
the ratio of viable cells in treated samples to viable cells in
control samples expressed as a percentage. All doses were tested
in triplicate and experiments were repeated at least three times.2.4. Annexin V-FITC/PI staining
Annexin V-FITC/PI double labeling was used for the detec-
tion of phosphatidylserine (PS) externalization, a hallmark of
the early phase of apoptosis. PS exposure on the outer layer of
cell membranes was measured using the annexin V-FITC
apoptosis detection kit (Biovision, USA) according to the
manufacturer’s instructions. Brieﬂy, after treatment with
different concentrations of CHE for 24 h, cells were harvested,
washed twice with cold PBS and resuspended in 200 mL
annexin V-FITC binding buffer. To this, 5 mL recombinant
annexin V-FITC was added and the mixture was incubated at
room temperature for 10–15 min in the dark. Following this,
5 mL 20 mg/mL PI solution was added and a total of 2 104
cells was analyzed using a BD FACSCalibur ﬂow cytometer
(Beckton–Dickinson, San Jose, CA, USA). Cells stained with
annexin V-FITC and PI were considered as late apoptotic or
necrotic cells while cells stained with annexin V-FITC alone
were considered as early apoptotic cells. All samples were
assayed in duplicate and experiments were repeated three
times.
Figure 2 Effect of CHE on BGC-823 cell viability as determined
by the MTT assay. Inhibition is expressed as cell viability relative
to control without CHE treatment. The cells (2 104/well) were
treated with different concentrations of CHE for 24, 36 and 48 h.
Data are means7S.D. of three independent experiments.
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After treatment with different concentrations of CHE for 24 h,
cells were harvested and washed twice with cold PBS. Total
DNA was isolated using a DNA extraction kit (Applygen,
China), analyzed by electrophoresis on 1% agarose gel
containing ethidium bromide and photographed by Bio-Rad
GD2000 (Bio-Rad, Hercules, CA, USA).
2.6. Cell cycle analysis
Cells in log-phase growth were treated with different concen-
trations of CHE for 24 h, trypsinized, resuspended, and ﬁxed
with cold 70% ethanol at 4 1C overnight. Fixed cells were
subsequently washed in PBS, resuspended in 1.0 mL PBS
containing 50 mg/mL RNase and 50 mg/mL PI and incubated
for 30 min at 37 1C. DNA content was then determined using
a BD FACSCalibur ﬂow cytometer. The percentage of cells in
G0/G1, S and G2/M phases was determined using Cellquest
3.0 software measuring 10,000 events in each case.
2.7. Mitochondrial membrane potential (Dcm)
Dcm was determined by 5,50,6,60-tetrachloro-1,103,30-tetraethyl-
benzimidazol-carbocyanine iodide (JC-1) staining using the
mitochondrial membrane potential detection kit (Mountain
View, CA) according to the manufacturer’s instructions. Brieﬂy,
after treatment with different concentrations of CHE for 24 h,
cells were harvested, washed, resuspended in 5 mg/mL JC-1
solution (500 mL) and incubated at 37 1C for 20 min. Cells were
washed, resuspended in cold PBS (500 mL) and ﬂuorescence of
10,000 cells per sample was measured by ﬂow cytometry using
excitation at 488 nm with emission at 525 nm for the green JC-1
monomers (FL1) and at 575 nm for the red JC-1 aggregates
(FL2). Data were analyzed using a FACSCalibur ﬂow cyto-
meter equipped with Cellquest 3.0 software. All samples were
assayed in duplicate and experiments were repeated three times.
2.8. Protein and Western blot analyses
After treatment with different concentrations of CHE for 24 h,
106 cells were harvested, washed, and lysed for 15 min on ice in
100 mL SDS lysis buffer (containing ﬁnal concentrations of
2% SDS, 10% glycerol and 62.5 mmol/L Tris, pH 6.8). The
protein concentration in the lysates was measured using the
BCA protein assay (Pierce Chemical Co., Rockford, USA)
according to the manufacturer’s protocol. For Western blot
analysis, protein samples (50 mg) from each cell lysate were
separated on SDS–PAGE gels (10% for all proteins except
cytochrome c where a 15% gel was used) and then electro-
transferred onto immobilon membranes (Millipore, Waltham,
Massachusetts, USA). Blots were blocked using 5% nonfat
milk in TBST buffer (25 mM Tris HCl, 0.2 M NaCl, 0.1%
Tween 20) for 2 h at room temperature and then incubated
overnight at 4 1C with primary antibodies (200 mg/mL and
dilutions of 1:1000 for Bax, Bad, Bcl-2, Bcl-XL, cytochrome c,
caspase-3 and PARP 1 mg/mL and dilution of 1:2500 for
b-actin). Blots were washed with TBST buffer (3 5 min) and
incubated with goat anti-rabbit antibodies conjugated with
horseradish peroxidase (1 mg/mL and dilution at 1:2000) for
1 h at room temperature. Blots were developed by enhancedchemiluminescence (ECL Kits; Amersham Life Science) fol-
lowed by exposure to X-ray ﬁlm using b-actin as loading
control. Protein expression in treated cells was compared to
untreated controls.
2.9. Release of cytochrome c
After treatment with different concentrations of CHE for 7 h,
106 cells were harvested, washed twice with ice-cold PBS and
then resuspended in 100 mL buffer (50 mM Tris–HCl pH 7.4,
1 mM NaF, 150 mM NaCl, 1 mM EGTA, 1 mM PMSF, 1%
v/v Nonidet P 40 (NP-40) and 10 mg/mL leupeptin). Samples
were centrifuged at 10,000 g for 30 min at 4 1C and the
supernatant (cytosolic fraction) was used to assess release of
cytochrome c. The remainder of the procedure was the same
as that for other Western blot analysis.
2.10. Statistical analysis
Results are expressed as means7S.D. of three independent
experiments. Differences in mean values were analyzed by the
Student’s t-test with a value of Po0.05 considered statistically
signiﬁcant.3. Results
3.1. Effect of CHE on cell viability
As shown in Fig. 2, cell growth inhibition by CHE was both
dose- and time-dependent. Cell growth inhibition increased
notably with increasing CHE concentration and decreased
with time with IC50 values of 2.42, 1.90, and 1.28 mg/mL for
24, 36, and 48 h, respectively.
3.2. CHE-induced apoptosis and cell cycle arrest
As shown in Fig. 3A, treatment with CHE for 24 h caused
the percentage of early apoptotic cells (annexin V-FITC
positive, and PI negative) signiﬁcantly increase from 4.7 to
27.7%. At the same time, the percentage of late apoptotic or
Figure 3 (A) Flow cytometric analysis of apoptosis with annexin-V/PI staining. Cells were treated with different concentrations of CHE
for 24 h and then labeled with a combination of annexin V-FITC/PI. Lower left quadrant (LL; annexin V and PI negative) represents
viable cells; Lower right quadrant (LR; annexin V positive and PI negative) represents apoptotic cells in early stage; Upper right quadrant
(UR; annexin V and PI positive) represents late apoptotic or necrotic cells; Upper left quadrant (UL; annexin V negative and PI positive)
represents necrotic cells or cellular debris. Numbers refer to the percentage of annexin-V and/or PI-labeled cells. (B) Agarose gel
electrophoresis of DNA ladders in BGC-823 cells. After treatment with CHE for 24 h, DNA in BGC-823 cells was extracted and loaded
on agarose gel. After electrophoresis, DNA ladders were photographed by BioRad GD2000 (bp). A: DNA marker; B: Control;
C: 1.25 mg/mL; D: 2.5 mg/mL; E: 5.0 mg/mL; F: 10.0 mg/mL.
Table 1 The relative proportion of cells (%) in the
G0/G1, S, and G2/M phases after treatment with CHE
for 24 h. Data are means7S.D. of three independent
experiments.
CHE
(mg/mL)
Cell cycle distribution (%)
G0/G1 S G2/M
Control 67.5377.65 15.273.43 17.6772.08
1.25 62.0875.29 21.372.97 15.1573.16
2.5 53.1173.85 29.677.11 15.6172.98
5.0 52.9578.98 37.478.27 12.6070.77
10.0 52.5277.34 39.6710.02 10.5272.63
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dose-dependent manner. Degradation of DNA into a speciﬁc
fragmentation pattern (consisting of DNA ladders) is a
characteristic feature of apoptosis16. Agarose gel electrophor-
esis of the DNA from BGC-823 cells exposed to CHE revealed
formation of clear DNA fragmentation ladders in a dose-
dependent manner (Fig. 3B).
It has been previously demonstrated that CHE can induce
G1 phase arrest in cancer cells17. In the present study, the
effect of CHE on the cell cycle was determined by ﬂow
cytometry of PI stained BGC-823 cells. As shown in Table 1
and Fig. 4, treatment with CHE for 24 h resulted in an
accumulation of cells in the S phase of the cell cycle from
15.2 to 39.6% while the number of cells in the G0/G1 and
G2/M phases decreased in a dose-dependent manner. The
Figure 4 Representative histograms of ﬂow cytometric analysis of cell cycle phase distribution in BGC-823 cells after treatment with
CHE. Cells were treated for 24 h with 1.25, 2.5, 5.0 and 10.0 mg/mL CHE, harvested, ﬁxed and stained for their DNA content with PI.
Results are based on three independent experiments.
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through S phase arrest.
3.3. Mitochondrial membrane potential and cytochrome c
release
The results show that CHE treatment of BGC-823 cells leads
to a dramatic shift in ﬂuorescence (Fig. 5A) and increase in
mitochondrial membrane depolarization from 34.4 to 98.4%
in a dose-dependent manner (Fig. 5B). In addition, cyto-
chrome c is released from mitochondria into the cytosol in a
dose-dependent manner (Fig. 6A). These observations suggest
CHE-induced apoptosis in BGC-823 cells involves cytochrome
c release from mitochondria and possibly mitochondrial
disruption.
3.4. Activation of caspase 3 and PARP cleavage
A role for caspase 3 in CHE-mediated induction of apoptosis
in BGC-823 cells is shown by formation of the cleaved forms
of caspase 3 (19 and 17 kDa fragments) in a dose-dependent
manner (Fig. 6A). Similarly, a role for the cleavage of PARP is
shown by the gradual increase in PARP fragments in the CHE
treated samples (Fig. 6A). These results conﬁrm the involve-
ment of caspase 3 activation and PARP cleavage in CHE-
induced apoptosis of BGC-823 cells.3.5. Expression of Bcl-2 family proteins
To further elucidate the molecular mechanism of CHE-
mediated apoptosis induction, the expression of several mem-
bers of the Bcl-2 family was examined by Western blot
analysis. As shown in Fig. 6B, the expressions of Bcl-xl and
Bcl-2 are down-regulated in a dose-dependent manner while
the expression of Bax is unchanged. The results reveal that
dysregulation of Bcl-2 family proteins is involved in CHE-
mediated apoptosis of BGC-823 cells.4. Discussion
Apoptosis, also known as programmed cell death, is closely
related to the initiation, progression and metastasis of tumors18,19
and its induction is a basic strategy in the treatment of malignant
tumors. In fact, most of the available chemotherapeutic agents
work by destroying tumor cells through inducing apoptosis20.
Cellular growth and proliferation are closely related to apopto-
sis21,22 which is characterized by distinct morphological changes
including plasma membrane bleb, cell shrinkage, PS translocation
and DNA fragmentation23,24.
During a cellular screening of benzophenanthridine alka-
loids, we found that CHE, the major active ingredient in
Macleaya cordata, interacts with DNA bases25–27, inhibits
proliferation of human gastric carcinoma BGC-823 cells and
Figure 5 Induction of mitochondrial depolarization of BGC-823 cells treated with CHE at 1.25, 2.5, 5.0 and 10.0 mg/mL for 24 h. (A)
representative histograms stained with the ﬂuorescent probe JC-1; (B) percentage of cells with low mitochondrial potential. Data are
means7S.D. of three independent experiments.
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apoptosis induction by CHE seems to be complex10,14,15, and
the molecular mechanism of its anticarcinogenic effect is notfully understood. In this study, we evaluated the ability of
CHE to induce apoptosis in BGC-823 cells and investigated
how it occurs.
Figure 6 (A) Expression of cytochrome c, caspase-3 and PARP
in CHE-treated BGC-823 cells. Cells were treated with different
concentrations of CHE for 24 h followed by Western blot analysis
for detection of cytochrome c, caspase-3 and PARP proteins.
b-Actin was used as an equal loading control. Results are based
on three independent experiments. (B) Expression of Bcl-2 family
proteins including Bcl-2, Bcl-xl and Bax in CHE-treated BGC-823
cells. Cells were treated with different concentrations of CHE for
24 h followed by Western blot analysis for detection of Bcl-2, Bcl-
xl and Bax proteins. b-Actin was used as an equal loading control.
Results are based on three independent experiments.
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BGC-823 cells in a dose- and time-dependent manner (Fig. 2)
consistent with previous studies in various cell types9–11.
Contrary to previous studies14,17, we observed positive
annexin V-FITC/PI staining (Fig. 3A) and DNA ladder
formation (Fig. 3B) indicating that CHE efﬁciently inhibits
BGC-823 cell growth through apoptosis with no change in cell
viability leading to necrosis of BGC-823 cells. There are two
key checkpoints that regulate the cell cycle, the G1/S and
G2/M transitions28,29. Anticancer drugs can disturb cell cycle
progression, arrest cells in a particular phase and induce
apoptosis. Despite the fact that CHE was shown to induce
G1 cell cycle arrest in human leukemia HL-60 cells17, our
results suggest that CHE causes signiﬁcant cell cycle arrest in
the S phase (Table 1 and Fig. 4).
As regards the mechanism of apoptosis induction, it is
known that apoptosis is regulated by two major signaling
pathways, namely the death receptor pathway and the mito-
chondrial pathway30,31. In the former, the binding of death
receptors with ligands such as Fas or cross-linking antibodies
results in initiation of the caspase cascade32. In the latter,
mitochondria are involved in a variety of key events leading to
apoptosis33,34. These include the collapse of Dcm and thesubsequent release of cytochrome c, both of which are
generally considered to play a central role in the early phase
of the mitochondrial pathway35,36. Cytochrome c is released
from mitochondria into the cytosol and forms the apoptosome
with Apaf-1 and procaspase 9, leading to activation of
executioner caspases including caspase 3. The activated cas-
pase 3 can cleave PARP which is an early and speciﬁc
indicator of apoptosis37.
As shown in Fig. 5A and 5B, CHE decreased Dcm in a
dose-dependent manner and CHE effectively induced cyto-
chrome c release from mitochondria into the cytosol. This
then activated caspase-3 to cleave PARP protein as shown in
Fig. 6A. These data are consistent with previous studies in
various cell types15. Bcl-2 family proteins have been reported
to regulate caspase activation by controlling mitochondrial
permeability and cytochrome c release36,38. The Bcl-2 family
includes anti-apoptotic proteins such as Bcl-2 and Bcl-xL and
pro-apoptotic proteins such as Bak and Bax39. It was reported
that changes in the ratio of pro- to anti-apoptotic members of
the Bcl-2 family, rather than the absolute expression level of
any single Bcl-2 member protein, determined apoptotic sensi-
tivity40. A study has shown that CHE can induce apoptosis by
inﬂuencing the balance of pro- and anti-apoptotic signaling
pathways41. In this investigation, the data show that down-
regulation of Bcl-xl and Bcl-2 proteins is involved in CHE-
induced apoptosis of BGC-823 cells (Fig. 6B).
Taken together, the results of this study clearly reveal that
induction of apoptosis by CHE involves multiple cellular and
molecular pathways. These include cell cycle arrest, reduction
in mitochondrial membrane potential, release of cytochrome c,
activation of caspase 3, PARP cleavage and dysregulation of
Bcl-2 family proteins. The present ﬁndings provide further
impetus to development of CHE as an effective agent for the
treatment of gastric cancer.
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